BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251210T083000
DTEND;TZID=America/Halifax:20251210T120000
DTSTAMP:20260419T110531
CREATED:20251206T001840Z
LAST-MODIFIED:20251206T001927Z
UID:10000455-1765355400-1765368000@oncodaily.com
SUMMARY:ESMO-IO SITC Primer Program
DESCRIPTION:The ESMO-IO SITC Primer Program is a joint educational event organized by the European Society for Medical Oncology (ESMO) and the Society for Immunotherapy of Cancer (SITC)\, scheduled for December 10\, 2025\, from 8:30 a.m. to 12:00 p.m. BST. \nThis half-day primer\, held at the Queen Elizabeth II Centre in London\, UK\, focuses on fundamental immuno-oncology (IO) concepts. \nThe program will cover current and emerging topics in immuno-oncology (IO)\, including neoadjuvant immunotherapy\, intratumoral immunotherapies\, recombinant cytokines\, and bispecific antibodies\, alongside new applications of AI\, spatial biology\, and multiomic approaches.
URL:https://oncodaily.com/event/esmo-422513
LOCATION:Queen Elizabeth II Centre in London\, United Kingdom\, Broad Sanctuary\, London SW1P 3EE\, London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMOSITC.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251210T080000
DTEND;TZID=Europe/London:20251212T170000
DTSTAMP:20260419T110531
CREATED:20250701T130014Z
LAST-MODIFIED:20250701T130110Z
UID:10000206-1765353600-1765558800@oncodaily.com
SUMMARY:ESMO Immuno-Oncology Congress 2025
DESCRIPTION:The ESMO Immuno-Oncology Congress 2025 will be held from 10 to 12 December 2025 as a hybrid event\, both onsite in London\, UK\, and online. This leading international congress brings together experts from around the globe to explore the full spectrum of immuno-oncology from basic science and translational research to clinical advancements. Attendees can expect cutting-edge sessions\, in-depth learning opportunities\, and dynamic networking with peers\, researchers\, and industry leaders. \nThe programme includes immersion sessions focused on immunobiology and translational insights\, updates on checkpoint inhibitor-based therapies\, and the latest in immune modulation including tumour microenvironment\, immunometabolism\, and cell signaling. Participants will also engage with industry and independent investigators to explore developments in cellular therapies\, cancer vaccines\, intratumoural immunotherapy\, and multispecific constructs. \nWhether attending in person or online\, the congress offers a valuable platform to share research\, expand knowledge\, and shape the future of cancer immunotherapy. \nRegistration is Open for the Event. \nMore posts featuring ESMO.
URL:https://oncodaily.com/event/esmo-immuno-oncology-congress-2025-321830
LOCATION:Queen Elizabeth II Centre in London\, United Kingdom\, Broad Sanctuary\, London SW1P 3EE\, London\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_6227.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR